UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August, 2023.
Commission File Number: 001-39530
ImmunoPrecise Antibodies Ltd.
(Exact Name of Registrant as Specified in Charter)
3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F □ Form 40-F ⊠
INCORPORATION BY REFERENCE
Exhibits 5.1, 10.1, and 23.1 of this Form 6-K are incorporated by reference into the Registrant's Registration Statement on Form F-3 (File No. 333-273197).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
IMMUNOPRECISE ANTIBODIES LTD. | |||
Date: August 15, 2023 | By: | /s/ Brad McConn | |
Name: | Brad McConn | ||
Title: | Chief Financial Officer |
EXHIBIT INDEX
Opinion of Bennett Jones LLP regarding legality of securities being registered | |
23.1 | Consent of Bennett Jones LLP (included in Exhibit 5.1) |